These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


147 related items for PubMed ID: 10398696

  • 1. The block of Shaker K+ channels by kappa-conotoxin PVIIA is state dependent.
    Terlau H, Boccaccio A, Olivera BM, Conti F.
    J Gen Physiol; 1999 Jul; 114(1):125-40. PubMed ID: 10398696
    [Abstract] [Full Text] [Related]

  • 2. A marine snail neurotoxin shares with scorpion toxins a convergent mechanism of blockade on the pore of voltage-gated K channels.
    García E, Scanlon M, Naranjo D.
    J Gen Physiol; 1999 Jul; 114(1):141-57. PubMed ID: 10398697
    [Abstract] [Full Text] [Related]

  • 3. kappa-Conotoxin PVIIA is a peptide inhibiting the shaker K+ channel.
    Shon KJ, Stocker M, Terlau H, Stühmer W, Jacobsen R, Walker C, Grilley M, Watkins M, Hillyard DR, Gray WR, Olivera BM.
    J Biol Chem; 1998 Jan 02; 273(1):33-8. PubMed ID: 9417043
    [Abstract] [Full Text] [Related]

  • 4. The binding of kappa-Conotoxin PVIIA and fast C-type inactivation of Shaker K+ channels are mutually exclusive.
    Koch ED, Olivera BM, Terlau H, Conti F.
    Biophys J; 2004 Jan 02; 86(1 Pt 1):191-209. PubMed ID: 14695262
    [Abstract] [Full Text] [Related]

  • 5. Binding of kappa-conotoxin PVIIA to Shaker K+ channels reveals different K+ and Rb+ occupancies within the ion channel pore.
    Boccaccio A, Conti F, Olivera BM, Terlau H.
    J Gen Physiol; 2004 Jul 02; 124(1):71-81. PubMed ID: 15226365
    [Abstract] [Full Text] [Related]

  • 6. Binding of κ-Conotoxin-PVIIA to Open and Closed Shaker K-Channels Are Differentially Affected by the Ionic Strength.
    Naranjo D, Díaz-Franulic I.
    Mar Drugs; 2020 Oct 26; 18(11):. PubMed ID: 33114777
    [Abstract] [Full Text] [Related]

  • 7. Solution structure and proposed binding mechanism of a novel potassium channel toxin kappa-conotoxin PVIIA.
    Scanlon MJ, Naranjo D, Thomas L, Alewood PF, Lewis RJ, Craik DJ.
    Structure; 1997 Dec 15; 5(12):1585-97. PubMed ID: 9438859
    [Abstract] [Full Text] [Related]

  • 8. Slow inactivation in voltage gated potassium channels is insensitive to the binding of pore occluding peptide toxins.
    Oliva C, González V, Naranjo D.
    Biophys J; 2005 Aug 15; 89(2):1009-19. PubMed ID: 15923220
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of single Shaker K channels by kappa-conotoxin-PVIIA.
    Naranjo D.
    Biophys J; 2002 Jun 15; 82(6):3003-11. PubMed ID: 12023223
    [Abstract] [Full Text] [Related]

  • 10. Alternative splicing in the pore-forming region of shaker potassium channels.
    Kim M, Baro DJ, Lanning CC, Doshi M, Farnham J, Moskowitz HS, Peck JH, Olivera BM, Harris-Warrick RM.
    J Neurosci; 1997 Nov 01; 17(21):8213-24. PubMed ID: 9334397
    [Abstract] [Full Text] [Related]

  • 11. Identification of a mammalian target of kappaM-conotoxin RIIIK.
    Ferber M, Al-Sabi A, Stocker M, Olivera BM, Terlau H.
    Toxicon; 2004 Jun 15; 43(8):915-21. PubMed ID: 15208025
    [Abstract] [Full Text] [Related]

  • 12. Molecular simulation of the interaction of kappa-conotoxin-PVIIA with the Shaker potassium channel pore.
    Moran O.
    Eur Biophys J; 2001 Dec 15; 30(7):528-36. PubMed ID: 11820396
    [Abstract] [Full Text] [Related]

  • 13. Why the Drosophila Shaker K+ channel is not a good model for ligand binding to voltage-gated Kv1 channels.
    Mahdavi S, Kuyucak S.
    Biochemistry; 2013 Mar 05; 52(9):1631-40. PubMed ID: 23398369
    [Abstract] [Full Text] [Related]

  • 14. Single amino acid substitutions in kappa-conotoxin PVIIA disrupt interaction with the shaker K+ channel.
    Jacobsen RB, Koch ED, Lange-Malecki B, Stocker M, Verhey J, Van Wagoner RM, Vyazovkina A, Olivera BM, Terlau H.
    J Biol Chem; 2000 Aug 11; 275(32):24639-44. PubMed ID: 10818087
    [Abstract] [Full Text] [Related]

  • 15. Three-dimensional structure of kappa-conotoxin PVIIA, a novel potassium channel-blocking toxin from cone snails.
    Savarin P, Guenneugues M, Gilquin B, Lamthanh H, Gasparini S, Zinn-Justin S, Ménez A.
    Biochemistry; 1998 Apr 21; 37(16):5407-16. PubMed ID: 9548922
    [Abstract] [Full Text] [Related]

  • 16. U-type inactivation of Kv3.1 and Shaker potassium channels.
    Klemic KG, Kirsch GE, Jones SW.
    Biophys J; 2001 Aug 21; 81(2):814-26. PubMed ID: 11463627
    [Abstract] [Full Text] [Related]

  • 17. Studies of Conorfamide-Sr3 on Human Voltage-Gated Kv1 Potassium Channel Subtypes.
    López-Vera E, Martínez-Hernández L, Aguilar MB, Carrillo E, Gajewiak J.
    Mar Drugs; 2020 Aug 13; 18(8):. PubMed ID: 32823677
    [Abstract] [Full Text] [Related]

  • 18. A novel conus peptide ligand for K+ channels.
    Ferber M, Sporning A, Jeserich G, DeLaCruz R, Watkins M, Olivera BM, Terlau H.
    J Biol Chem; 2003 Jan 24; 278(4):2177-83. PubMed ID: 12399472
    [Abstract] [Full Text] [Related]

  • 19. KCNA10: a novel ion channel functionally related to both voltage-gated potassium and CNG cation channels.
    Lang R, Lee G, Liu W, Tian S, Rafi H, Orias M, Segal AS, Desir GV.
    Am J Physiol Renal Physiol; 2000 Jun 24; 278(6):F1013-21. PubMed ID: 10836990
    [Abstract] [Full Text] [Related]

  • 20. Open channel block of HERG K(+) channels by vesnarinone.
    Kamiya K, Mitcheson JS, Yasui K, Kodama I, Sanguinetti MC.
    Mol Pharmacol; 2001 Aug 24; 60(2):244-53. PubMed ID: 11455010
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.